Contact Contact Information FOR INVESTORS Elisabeth Schwartz Email: investor.relations@amarincorp.com FOR ADVERSE EVENTS RELATED TO VASCEPA Email: AmarinMI@druginfo.com Phone: 1-855-VASCEPA, 1-855-827-2372 FOR MEDIA Gwen Fisher Email: pr@amarincorp.com